Evidence map›Paper›PMID 37763353›Full record

ReviewMaterials (Basel, Switzerland)2023

Chitosan and Its Derivatives: Preparation and Antibacterial Properties.

Anton R Egorov, Anatoly A Kirichuk, Vasili V Rubanik, Vasili V Rubanik, Alexander G Tskhovrebov, Andreii S Kritchenkov

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Research Progress in Medical Biomaterials for Bone Infections.Journal of functional biomaterials · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anton R EgorovDepartment of Human Ecology and Biolementology, RUDN University, 6 Miklukho-Maklaya St., 117198 Moscow, Russia.ORCID 0000-0002-6006-6883
Anatoly A KirichukDepartment of Human Ecology and Biolementology, RUDN University, 6 Miklukho-Maklaya St., 117198 Moscow, Russia.
Vasili V RubanikInstitute of Technical Acoustics NAS of Belarus, Ludnikova Prosp. 13, 210009 Vitebsk, Belarus.ORCID 0000-0002-0350-1180
Vasili V RubanikInstitute of Technical Acoustics NAS of Belarus, Ludnikova Prosp. 13, 210009 Vitebsk, Belarus.
Alexander G TskhovrebovDepartment of Human Ecology and Biolementology, RUDN University, 6 Miklukho-Maklaya St., 117198 Moscow, Russia.ORCID 0000-0002-4445-2530
Andreii S KritchenkovDepartment of Human Ecology and Biolementology, RUDN University, 6 Miklukho-Maklaya St., 117198 Moscow, Russia.ORCID 0000-0002-6411-5988

Funding

Russian Science Foundation 22-23-00044
6 · The paper itself

Abstract

This comprehensive review illuminates the various methods of chitosan extraction, its antibacterial properties, and its multifarious applications in diverse sectors. We delve into chemical, physical, biological, hybrid, and green extraction techniques, each of which presents unique advantages and disadvantages. The choice of method is dictated by multiple variables, including the desired properties of chitosan, resource availability, cost, and environmental footprint. We explore the intricate relationship between chitosan's antibacterial activity and its properties, such as cationic density, molecular weight, water solubility, and pH. Furthermore, we spotlight the burgeoning applications of chitosan-based materials like films, nanoparticles, nonwoven materials, and hydrogels across the food, biomedical, and agricultural sectors. The review concludes by highlighting the promising future of chitosan, underpinned by technological advancements and growing sustainability consciousness. However, the critical challenges of optimizing chitosan's production for sustainability and efficiency remain to be tackled.

Indexed as

antibacterial activitychitosanfilmshydrogelsnanoparticlesnonwoven materials

Identifiers

PMID37763353
PMCPMC10532898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.